The alpha folate receptor is highly activated in malignant pleural mesothelioma.
about
Targeting folate receptor alpha for cancer treatmentA current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancerFarletuzumab in lung cancerStructures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognitionInhibitor of apoptosis protein-1 promotes tumor cell survival in mesotheliomaFolate receptor-targeted ultrasonic PFOB nanoparticles: Synthesis, characterization and application in tumor-targeted imaging.Functional folate receptor alpha is elevated in the blood of ovarian cancer patients.Antimetabolites and cancer: emerging data with a focus on antifolates.The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.Folate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease.An epigenetic mechanism for capecitabine resistance in mesotheliomaFolate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.Pharmacogenetics and folate metabolism -- a promising direction.Future potential of thymidylate synthase inhibitors in cancer therapy.Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis.Malignant pleural mesothelioma--an update.Characterization of the human folate receptor alpha via novel antibody-based probes.Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.Current chemotherapeutic treatment of malignant pleural mesothelioma.Chemotherapy options and new advances in malignant pleural mesothelioma.High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutationA fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity.Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4.Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease.Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the futureDelivery of calf thymus DNA to tumor by folate receptor targeted cationic liposomes.Folate-immunoglobulin G as an anticancer therapeutic antibody.Methotrexate and gemcitabine combination chemotherapy for the treatment of malignant pleural mesothelioma.Clinical translation of folate receptor-targeted therapeutics.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.Multifunctional nanoassemblies of block copolymers for future cancer therapy.Intraoperative near-infrared imaging of mesothelioma.Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.Folate conjugated phosphorylcholine-based polycations for specific targeting in nucleic acids delivery.Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Müllerian origin, and primary lung adenocarcinoma.Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform.Phase I clinical trial of 99mTc-etarfolatide, an imaging agent for folate receptor in healthy Japanese adults.Identification of a peptide for folate receptor alpha by phage display and its tumor targeting activity in ovary cancer xenograft.
P2860
Q26744215-20F28112-DFE2-447C-93DA-2184856EAE30Q26781856-7DBD1B3D-3F77-4BAE-8F66-887DF72D2211Q26997008-B44B7119-6F22-4E48-8EDA-58EA2B8B7CB2Q27679502-194CB7A7-54A0-4188-9149-F7FEA4A3477DQ28206578-6542E8AC-9C74-4EE9-958F-D2DCA3C9829AQ30356285-423E5F5B-83EF-444B-AA8C-A663CC39B45FQ33484181-21DF4466-0887-4BC4-9CC3-4CC38E568021Q33530405-C451FB1A-EC84-4714-8644-1E089A6868E6Q33658554-E2E4FE9E-9739-4DE7-9246-E119B78254F6Q33734661-2B9C3669-1311-4C82-A6D8-15C44E1B002BQ33813008-8CCD19BA-2054-4C0A-9583-86FDC60AF7CFQ34033606-B386EE44-171A-4FEC-8D97-4C16794EBC51Q34673321-C8D8EE6E-B8B2-4466-9B80-1E9C4B0689ECQ35011904-9974E87B-2D23-4CB6-945F-36FF366AB9D9Q35639774-DAF39824-4457-4C38-83FE-B8DE2F9545B3Q35740408-78CF12FC-37EE-4E94-B405-796CC85567FEQ35764371-EAFEECF2-17B5-4ED0-9AC8-F3103646F995Q35854305-2253D3A3-7590-41DF-857A-4EBF8341D02AQ35967314-48F5DB70-16B1-4C13-8D98-9C93B86F8CC1Q36022779-E7B79C4D-3403-4038-A2A9-5F10BC190563Q36059727-53722157-DA33-4748-8CDC-C68F425DE8A8Q36356392-8250D60C-9CF7-4209-BF99-2C56A32F3C78Q36808757-B25D22E2-0944-436D-923E-F9D39811318CQ37052124-E07E048C-24AB-46AD-81C5-0642347188D9Q37090808-E0209460-EBF4-44C8-9745-17DE664616E0Q37253982-40106CC1-31E5-48A9-827E-757542F1F551Q37267004-95B45CEE-1E0C-461E-A399-3C8831185654Q37562633-DC232564-B736-40A2-A50F-9FFF945534EBQ38015901-61B21D97-4BB1-4AAA-B807-E6EC813EEE69Q38259956-9BB0B8EA-F4D3-434B-9E91-0A7423407E53Q38940035-EEB2FA84-4A67-434C-BFA6-9479F00C9D06Q39017324-7709EAC9-618D-4999-8C04-36BEEFC80B61Q39438162-3E6008A6-CF06-498A-84B0-F7042E52C3DEQ39788190-16DB6B7B-B8B7-4F1F-BAC0-79CE63B82B7BQ39836884-45B45B7D-AED1-4400-8302-CD9539A929B9Q39997968-2BE39FFE-F299-4650-99E2-FCC6EF6B5E55Q42717206-F4E4D281-372A-47F5-B9D3-62FF5776B614Q51792729-68EF5B4A-D1B2-4058-ACFA-658238491486Q53396871-CD39B282-D047-4371-85BB-1DD9AC4F50CBQ55061789-408BE597-A796-40C8-939C-42BEBC5D7606
P2860
The alpha folate receptor is highly activated in malignant pleural mesothelioma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The alpha folate receptor is highly activated in malignant pleural mesothelioma.
@ast
The alpha folate receptor is highly activated in malignant pleural mesothelioma.
@en
type
label
The alpha folate receptor is highly activated in malignant pleural mesothelioma.
@ast
The alpha folate receptor is highly activated in malignant pleural mesothelioma.
@en
prefLabel
The alpha folate receptor is highly activated in malignant pleural mesothelioma.
@ast
The alpha folate receptor is highly activated in malignant pleural mesothelioma.
@en
P2093
P356
P1476
The alpha folate receptor is highly activated in malignant pleural mesothelioma.
@en
P2093
P304
P356
10.1067/MTC.2001.111176
P407
P577
2001-02-01T00:00:00Z